CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...
UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...
As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The U.S. health agency, the Centers for Medicare & Medicaid Services (CMS), announced Tuesday that it will appeal a November 2024 ruling to the Fifth Circuit Court of Appeals. What Happened: In ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.
My primary care doctor's office is a small one, and he will be retiring soon, so I need to find a new doctor. I recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback